Biotech Law

The government’s case against Stryker Biotech and three of its executives was set to be a rare instance of an off-label marketing case going before a jury. But after only two days of trial, the Boston U.S. attorney’s office reached … Continue reading →

Adrian G. Torres, Michael J. Gait. Efficient cellular delivery is one of the key issues that has hampered the therapeutic development of novel synthetic biomolecules such as oligonucleotides, peptides and nanoparticles. The highly ….

Law360, New York (January 18, 2012, 4:14 PM ET) — Stryker Biotech LLC reached a plea agreement Wednesday in Massachusetts federal court under which it will pay $15 million to end a criminal case over illegal marketing of a bone … Continue reading →

except as required under applicable law. PROLOR CONTACT: MEDIA CONTACT: Shai Novik, President Barbara Lindheim PROLOR Biotech, Inc. GendeLLindheim BioCom Partners Tel: +1 866 644-7811 +1 212 584-2276, ext. 201 Email: shai@prolor-biotech.com …

Although the law will be limited to some states, it will be the first time that there will be a specified national law for standards of treatment that could also result in penalty for errant healthcare service providers. The health … Continue reading →

Teresa Lopes da Silva, José Carlos Roseiro, Alberto Reis. Conventional microbiology methods used to monitor microbial biofuels production are based on off-line analyses. The analyses are, unfortunately, insufficient for bioprocess optimization. Real time….

Bianco, Zazzali received his J.D. from Villanova University School of Law. Jill Ann Mello, Ph.D. (Boston) – Mello is a member of the firm’s Intellectual Property/Information Technology practice. Her practice focuses on the biotechnology and pharmaceutical …

The Applikon case demonstrates the potential benefit of close company attention to tariff classifications affecting biotech products and the willingness to use new classifications where warranted by the facts and applicable law.

I’m happy to help.” Kathy Robertson covers health care, labor/workplace issues, law, immigration, medical technology and biotechnology for the Sacramento Business Journal.

Smaller biotech startups in and outside the life sciences seeking … the overhaul of U.S. Patent law enacted in September by President Barack Obama. From testimony at public hearings and written statements this fall, the patent office concluded …